Raynaud’s disease and Raynaud’s syndrome describe the same basic event: blood vessels in your fingers or toes spasm in response to cold or stress, temporarily cutting off blood flow and turning the skin white or blue. The difference comes down to whether this happens on its own or is driven by an underlying condition. Raynaud’s disease (also called primary Raynaud’s) has no identifiable cause, while Raynaud’s syndrome (secondary Raynaud’s) is linked to another illness, most often an autoimmune or connective tissue disease.
Why There Are Two Names
The terminology can be confusing because doctors have used the terms interchangeably for years, and you’ll also see both versions called “Raynaud’s phenomenon.” In current medical practice, the distinction that matters is primary versus secondary. Primary Raynaud’s is a standalone condition. Your blood vessels overreact to cold or emotional stress, but there’s no structural damage and no other disease behind it. Secondary Raynaud’s is a symptom of something else, and that something else changes the outlook significantly.
Who Gets Each Type
Primary Raynaud’s is far more common. A large analysis of population studies found that roughly 5% of the general population has it, with women affected slightly more often than men (about 5.7% of women versus 4.1% of men). It typically shows up between ages 15 and 30, and a family history raises your risk.
Secondary Raynaud’s is less common overall but tends to appear later, usually around age 40. It occurs most frequently alongside autoimmune diseases: scleroderma, lupus, rheumatoid arthritis, Sjögren’s disease, and inflammatory myositis are the conditions most closely linked to it. It can also develop from repetitive vibration injuries (like years of operating power tools), certain medications, or blood vessel disorders.
What Happens Inside the Blood Vessels
In primary Raynaud’s, the problem is purely functional. The blood vessels themselves are structurally normal, but they clamp down too aggressively when triggered. One theory is that people with primary Raynaud’s have a defect in how their nervous system adapts to stress. Normally, your body learns to moderate its fight-or-flight response to repeated triggers. In primary Raynaud’s, that adaptation doesn’t happen as efficiently, so the same cold exposure keeps producing the same exaggerated blood vessel spasm.
Secondary Raynaud’s involves actual physical changes to the blood vessels. The inner lining of small arteries becomes thickened with scar-like tissue, which narrows the channel blood flows through. On top of that, the cells lining those vessels become damaged, which disrupts the balance of chemicals that tell vessels to open and close. The result is a double problem: vessels that are both structurally narrowed and functionally prone to clamping shut. This is why secondary Raynaud’s tends to be more severe and harder to manage.
Symptoms: Mild Versus Serious
Both types produce the classic color change in fingers or toes. Skin turns white as blood flow stops, then blue as oxygen runs out, then red as blood rushes back in. This sequence can take minutes to over an hour. In primary Raynaud’s, episodes are uncomfortable but generally harmless. The fingers may feel numb or tingly, and once blood flow returns, there’s often a throbbing or stinging sensation. But the tissue recovers fully each time.
Secondary Raynaud’s can produce the same episodes but with higher stakes. Because the blood vessels are structurally compromised, some attacks cut off blood flow long enough to damage tissue. The main complications are digital ulcers (open sores on the fingertips that heal slowly), tissue death at the tips of the fingers, and in severe cases, loss of part of a digit. These complications are especially common in people with scleroderma.
How Doctors Tell Them Apart
If you go to a doctor with Raynaud’s symptoms, the main goal is figuring out whether this is primary or secondary, because the answer shapes everything about treatment and monitoring.
Two tools are especially useful. The first is a blood test for antinuclear antibodies (ANA), which are markers of autoimmune activity. In one study of 138 patients with Raynaud’s, 53% tested positive for ANA, and those with positive results were significantly more likely to have an underlying systemic disease. Specific antibody patterns can even point toward particular conditions. Anticentromere antibodies, for instance, showed up in 70% of patients with a form of scleroderma called CRST syndrome.
The second tool is nailfold capillary microscopy, a painless exam where a doctor uses a magnifying device to look at the tiny blood vessels along the base of your fingernails. In primary Raynaud’s, these capillaries look normal. In secondary Raynaud’s, they show characteristic damage: enlarged or “giant” capillaries, areas where capillaries have dropped out entirely, and sometimes tiny hemorrhages. One study found capillary loss in about 44% of secondary Raynaud’s patients compared to only 16% of primary cases. This test can sometimes detect secondary Raynaud’s before the underlying disease has fully declared itself.
Treatment for Primary Raynaud’s
Primary Raynaud’s is nonprogressive, meaning it doesn’t get worse over time or cause lasting damage. For most people, lifestyle changes are enough. That means keeping your whole body warm (not just your hands), wearing layered clothing in cold weather, using insulated gloves, and avoiding sudden temperature changes like reaching into a freezer. Stress management also helps, since emotional triggers can be just as potent as cold.
When lifestyle changes aren’t sufficient, doctors may prescribe a calcium channel blocker, a type of medication that relaxes blood vessel walls and reduces the frequency and severity of attacks. Topical treatments that release a vessel-relaxing compound through the skin can also help. Most people with primary Raynaud’s do well with these approaches and never need anything more aggressive.
Treatment for Secondary Raynaud’s
Secondary Raynaud’s often requires medication from the start, and the treatment plan is more complex because it has to address both the Raynaud’s symptoms and the underlying disease. Calcium channel blockers are still used as a first-line option, but many patients need additional therapies. These can include medications that block the chemical signals causing vessel constriction, drugs that improve blood flow in small vessels, or compounds originally developed for blood pressure or circulation problems that also help relax narrowed arteries.
For people who develop digital ulcers or signs of severe blood flow loss, treatment escalates. Intravenous medications that mimic the body’s natural vessel-opening compounds may be given during acute crises. Blood thinners can play a role when clotting abnormalities contribute to the problem. In cases where fingers are at risk of permanent damage and medications aren’t working, surgical options exist. These include injections that temporarily paralyze the nerves triggering vessel spasm and procedures that permanently cut the nerve signals causing constriction in the affected fingers.
Early recognition of secondary Raynaud’s matters because the underlying conditions, particularly scleroderma, can also affect internal organs. Treating the Raynaud’s is important on its own, but identifying the driving disease opens the door to therapies that can prevent broader complications well beyond the fingertips.